Blood pressure and graft outcome in renal transplantation, Transplant Proc, vol.37, pp.997-998, 2005. ,
The natural history of chronic allograft nephropathy, N Engl J Med, vol.349, pp.2326-2333, 2003. ,
Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation, Am J Kidney Dis, vol.48, pp.134-142, 2006. ,
A more selective costimulatory blockade of the CD28-B7 pathway, Transpl Int, vol.24, pp.2-11, 2011. ,
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig, N Engl J Med, vol.349, pp.1907-1915, 2003. ,
Costimulation blockade with belatacept in renal transplantation, N Engl J Med, vol.353, pp.770-781, 2005. ,
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study), Am J Transplant, vol.10, pp.535-546, 2010. ,
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients, Am J Transplant, vol.12, pp.210-217, 2012. ,
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study), Am J Transplant, vol.10, pp.547-557, 2010. ,
Belataceptbased regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies), Transplantation, vol.91, pp.976-983, 2011. ,
Alternatives to calcineurin inhibition in renal transplantation: Belatacept, the first co-stimulation blocker, Immunotherapy, vol.2, pp.625-636, 2010. ,
Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T-cells in organ transplantation, Sci Transl Med, vol.2, pp.17-27, 2010. ,
Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody, Am J Transplant, vol.12, pp.2630-2640, 2012. ,
CD28-specific immunomodulating antibodies: What can be learned from experimental models?, Am J Transplant, vol.12, pp.1682-1690, 2012. ,
Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner, Am J Transplant, vol.11, pp.1599-1609, 2011. ,
Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody, Blood, vol.102, pp.564-570, 2003. ,
Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses, Blood, vol.99, pp.2228-2234, 2002. ,
Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice, Biol Blood Marrow Transplant, vol.17, pp.962-969, 2011. ,
Programmed death-1 ligand 1 interacts specifically with the B 7-1 costimulatory molecule to inhibit T cell responses, Immunity, vol.27, pp.111-122, 2007. ,
Interaction of human PD-L1 and B7-1, Mol Immunol, vol.45, pp.3567-3572, 2008. ,
B7-h2 is a costimulatory ligand for CD28 in human, Immunity, vol.34, pp.729-740, 2011. ,
Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis, J Immunol, vol.163, pp.1704-1710, 1999. ,
FR255734, a humanized, Fc-Silent, Anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model, J Invest Dermatol, vol.128, pp.1969-1976, 2008. ,
CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens, J Clin Invest, vol.113, pp.1624-1630, 2004. ,
CD28-specific antibody prevents graft-versus-host disease in mice, J Immunol, vol.164, pp.4564-4568, 2000. ,
Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats, J Am Soc Nephrol, vol.13, pp.519-527, 2002. ,
Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection, Transplantation, vol.73, pp.1310-1317, 2002. ,
Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients, J Immunol, vol.179, pp.8164-8171, 2007. ,
Combination of donor-specific blood transfusion with anti-CD28 antibody synergizes to prolong graft survival in rat liver transplantation, Transplant Proc, vol.38, pp.3244-3246, 2006. ,
Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation, Transplantation, vol.67, pp.392-398, 1999. ,
Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells, Am J Transplant, vol.5, pp.2339-2348, 2005. ,
Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion, J Immunol, vol.180, pp.7898-7906, 2008. ,
Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5, J Immunol, vol.188, pp.4209-4216, 2012. ,
Antagonist properties of monoclonal antibodies targeting human CD28: Role of valency and the heavy-chain constant domain, MAbs, vol.5, pp.47-55, 2013. ,
Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons, Kidney Int, vol.78, pp.152-159, 2010. ,
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue, Cancer Res, vol.69, pp.599-608, 2009. ,
Acute humoral rejection of renal transplants in alloimmunized pigs, J Surg Res, vol.139, pp.261-268, 2007. ,
Recombinant human c1-inhibitor inhibits cytotoxicity induced by allo-and xenoantibodies, Transplant Proc, vol.40, pp.581-583, 2008. ,
Functional delineation and differentiation dynamics of human CD4þ T cells expressing the FoxP3 transcription factor, Immunity, vol.30, pp.899-911, 2009. ,
Natural and adaptive foxp3þ regulatory T cells: More of the same or a division of labor?, Immunity, vol.30, pp.626-635, 2009. ,
Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation, J Immunol, vol.182, pp.148-153, 2009. ,
Heliosþ and HeliosÀ cells coexist within the natural FOXP3þ T regulatory cell subset in humans, J Immunol, vol.190, pp.2001-2008, 2013. ,
CTLA-4,PD-L1 costimulation differentially controls immune synapses, function of human regulatory, conventional T-cells, PLoS ONE, vol.28, p.83139, 2013. ,
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412, N Engl J Med, vol.355, pp.1018-1028, 2006. ,
Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28, MAbs, vol.6, pp.697-707, 2014. ,
Calcineurin inhibitor minimization in the symphony study: Observational results 3 years after transplantation, Am J Transplant, vol.9, pp.1876-1885, 2009. ,
Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression, Transplantation, vol.84, pp.706-714, 2007. ,
Evidence for antibodymediated injury as a major determinant of late kidney allograft failure, Transplantation, vol.90, pp.68-74, 2010. ,
The spectrum of antibodymediated renal allograft injury: Implications for treatment, Am J Transplant, vol.8, pp.1367-1373, 2008. ,
Signals that influence T follicular helper cell differentiation and function, Semin Immunopathol, vol.32, pp.183-196, 2010. ,
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection, Am J Transplant, vol.14, pp.59-69, 2014. ,
Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF, Cancer Res, vol.69, pp.609-615, 2009. ,
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit, Proc Natl Acad Sci, vol.105, pp.20410-20415, 2008. ,
CTLA-4 control over Foxp3þ regulatory T cell function, Science, vol.322, pp.271-275, 2008. ,
Expression of Helios, an Ikaros transcription factor family member, differentiates thymicderived from peripherally induced Foxp3þ T regulatory cells, J Immunol, vol.184, pp.3433-3441, 2010. ,
tTregs, pTregs, and iTregs: Similarities and differences, Immunol Rev, vol.259, pp.88-102, 2014. ,
B7/CD28 costimulation is essential for the homeostasis of the CD4þ CD25þ immunoregulatory T cells that control autoimmune diabetes, Immunity, vol.12, pp.431-440, 2000. ,
Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression, J Immunol, vol.188, pp.1698-1707, 2012. ,
Inducing and expanding regulatory T cell populations by foreign antigen, Nat Immunol, vol.6, pp.1219-1227, 2005. ,
TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes, Nat Med, vol.9, pp.1202-1208, 2003. ,
TGF-beta induces Foxp3þ Tregulatory cells from CD4þ CD25À precursors, Am J Transplant, vol.4, pp.1614-1627, 2004. ,
All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation, J Exp Med, vol.204, pp.1765-1774, 2007. ,
Enhanced engagement of CTLA-4 induces antigenspecific CD4þ CD25þ Foxp3þ and CD4þ CD25À TGF-beta 1þ adaptive regulatory T cells, J Immunol, vol.179, pp.5191-5203, 2007. ,
Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade, Transpl Immunol, vol.17, pp.243-248, 2007. ,
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation, Am J Transplant, vol.8, pp.2086-2096, 2008. ,